Interleukin-18 induces transferrin expression in breast cancer cell line MCF-7

被引：29

作者：

Park, Sunyoung ^{[2
]}

Yoon, Sun Young ^{[2
]}

Kim, Kyung-Eun ^{[2
]}

Lee, Ha Reum ^{[2
]}

Hur, Dae Young ^{[3
,4
]}

Song, Hyunkeun ^{[3
,4
]}

Kim, Daejin ^{[5
]}

Bang, Sa Ik ^{[1
]}

Cho, Dae-Ho ^{[2
]}

机构：

[1] Sungkyunkwan Univ, Dept Plast Surg, Sch Med, Samsung Med Ctr, Seoul 135710, South Korea

[2] Sookmyung Womens Univ, Dept Life Sci, Seoul 140742, South Korea

[3] Inje Univ, Busan Paik Hosp, Dept Anat, Pusan, South Korea

[4] Inje Univ, Busan Paik Hosp, Res Ctr Womens Dis, Pusan, South Korea

[5] Chung Ang Univ, Coll Med, Dept Anat, Seoul 156756, South Korea

来源：

CANCER LETTERS | 2009年 / 286卷 / 02期

关键词：

Interleukin-18 (IL-18); Transferrin; Proliferation; Breast cancer; MURINE MELANOMA-CELLS; HUMAN GASTRIC-CANCER; GAMMA PRODUCTION; PATHWAY; IRON; GROWTH; SERUM; PROLIFERATION; CARCINOMA; RECEPTORS;

D O I：

10.1016/j.canlet.2009.05.025

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Interleukin-18 (IL-18) has recently been shown to have a pro-cancer effect in various cancers. Increased serum levels of both IL-18 and transferrin in cancer patients are correlated with its malignancy. However, the relationship between transferrin and IL-18 is not well understood. Here, we show that exogenous transferrin enhanced breast cancer cell proliferation and the proliferation rate was reduced when endogenous transferrin expression was inhibited by transferrin siRNA. The expression of endogenous transferrin was found to be regulated by IL-18. Furthermore, we found that the MAPK pathway is involved in IL-18-induced transferrin production. In conclusion, IL-18 is suggested as an inducer of endogenous transferrin expression in breast cancer cells. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

引用

页码：189 / 195

页数：7

共 50 条

[21] Estrogen stimulates adenosine receptor expression subtypes in human breast cancer MCF-7 cell line
Mohamadi, Azam
Aghaei, Mahmoud
Panjehpour, Mojtaba
RESEARCH IN PHARMACEUTICAL SCIENCES, 2018, 13 (01) : 57 - 64
[22] Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib
Chen, Chen
Shen, Hui Ling
Yang, Jing
Chen, Qiao Yun
Xu, Wen Lin
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (01) : 9 - 17
[23] MCF-7: The first hormone-responsive breast cancer cell line
Levenson, AS
Jordan, VC
CANCER RESEARCH, 1997, 57 (15) : 3071 - 3078
[24] Mathematical modeling of tumor growth: the MCF-7 breast cancer cell line
Wei, Hsiu-Chuan
MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2019, 16 (06) : 6512 - 6535
[25] HETEROGENEITY OF THE HUMAN-BREAST CANCER CELL-LINE MCF-7
BUTLER, B
BERLINSKI, PJ
KELSEY, WH
TOENNIGES, MM
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 236 - 236
[26] Expression of vitamin D-metabolizing enzymes in the human breast cancer cell line MCF-7
不详
ANTICANCER RESEARCH, 2005, 25 (3B) : 2284 - 2285
[27] Proteomic analysis of MCF-7 breast cancer cell line exposed to leptin
Valle, A.
Sastre-Serra, J.
Pol, C.
Miro, A. M.
Oliver, J.
Roca, P.
ANALYTICAL CELLULAR PATHOLOGY, 2011, 34 (03) : 147 - 157
[28] Identification of DNA palindromes in the MCF-7 breast cancer cell line.
Yang, Hui
Volfovsky, Natalia
Rattray, Alison
Chen, Xiongfong
Tanaka, Hisashi
Jeffrey, Strathern
CANCER RESEARCH, 2013, 73 (08)
[29] Multiparametric flow cytometric analysis in a breast cancer cell line (MCF-7)
Lee, GSR
Ryu, KS
Rha, JG
Kim, SP
Namkoong, SE
Han, KT
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2002, 28 (03) : 141 - 148
[30] Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib
Chen Chen
Hui Ling Shen
Jing Yang
Qiao Yun Chen
Wen Lin Xu
Journal of Cancer Research and Clinical Oncology, 2011, 137 : 9 - 17

← 1 2 3 4 5 →